Next, we performed KEGG pathway analyses of all quantified proteins [28–30] which showed a high coverage of genes annotated to be involved in the bladder cancer (Fig 1E), as well as associated pathways cell cycle, MAPK, TGF-beta, VEGF and p53 signaling (S1 File). The gene discussed is TP53; the disease is urinary bladder cancer.